Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:34 PM ET 8-K
Financial Results Host Hotels & Resorts, Inc. HST

Host Hotels & Resorts Financial Results

Host Hotels & Resorts reported Q3 2026 financial results with revenue of $1.35 billion and comparable hotel RevPAR growth of 8.8%. The company raised its full-year 2026 guidance for RevPAR and Total RevPAR following strong leisure and business transient demand. During the quarter, the company also completed the acquisitions of 1 Hotel Brooklyn Bridge and Renaissance Dallas at Plano Legacy West.

Term
Q3 2026

“We delivered a strong third quarter, driven by the quality of our portfolio, disciplined capital allocation and continued reinvestment in our assets. Comparable hotel RevPAR increased 8.8%, supported by rate growth and broad-based strength in leisure transient, group, and business transient demand.”

James F. Risoleo, President and Chief Executive Officer

“The acquisitions of the 1 Hotel Brooklyn Bridge and Renaissance Dallas at Plano Legacy West enhance our diversified portfolio with two market-leading properties that are expected to be immediately accretive to the Company.”

James F. Risoleo, President and Chief Executive Officer
4:33 PM ET 10-Q
Financial Results Adaptive Biotechnologies Corp ADPT

Adaptive Biotechnologies Q3 2026 Results: Net Income $2.88M, Down 69.9% YoY

Adaptive Biotechnologies reported a net loss of $57.2 million for the first nine months of 2026, compared to a $45.9 million loss in the prior year period, impacted by a $23.7 million loss on revenue interest liability extinguishment. Despite the year-to-date loss, the company achieved a quarterly net income of $2.9 million in Q3 2026, though revenue for the quarter decreased to $83.9 million from $94.0 million year-over-year.

Key figure
Net income $2.88M · -69.9% YoY
4:33 PM ET 10-Q
Financial Results Flowco Holdings Inc. FLOC

Flowco Holdings Q3 2026 Results: Net Income $20.1M, Up 60.8% YoY

Flowco Holdings Inc. is a holding company that completed its IPO on January 15, 2025, raising $491.3 million in gross proceeds. The company operates through Flowco LLC and its subsidiaries, including Estis and Flogistix, and is classified as a non-accelerated filer and an emerging growth company.

Key figure
Net income $20.1M · +60.8% YoY
4:33 PM ET 10-Q
Financial Results Veeco Instruments Inc VECO ▶ Call

Veeco Instruments Q3 2026 Results: Net Income $13.6M, Up 28.7% YoY

Veeco Instruments reported net sales of $209.4 million for the third quarter of 2026, a significant increase from $165.9 million in the prior year. Despite higher revenue, nine-month net income decreased to $25.2 million from $34.3 million year-over-year, primarily due to higher operating expenses and merger-related costs associated with the pending acquisition by Axcelis Technologies.

Key figure
Net income $13.6M · +28.7% YoY
4:33 PM ET Form 4
Insider Selling Ibotta, Inc. IBTA

Ibotta Chief People Officer Marisa Daspit Sells $36K of Stock

Marisa Daspit, Chief People Officer, sold 720 shares of Ibotta, Inc. at $50.01 a share, worth $36K in total on Nov 2, 2026. Shares held after the trade: 115,539 (-0.6%).

Value
$36K
Shares
720
Price
$50.01
Role
Chief People Officer
Holding change
-0.6%
Trade date
Nov 2, 2026
4:33 PM ET 10-Q
Financial Results Arq, Inc. ARQ

Arq Q3 2026 Results: Turns Profitable, Net Income $2.5M

Arq, Inc. reported a return to profitability in the third quarter of 2026 with net income of $2.5 million, compared to a net loss of $0.9 million in the prior year period. For the nine months ended September 30, 2026, revenue grew to $97.1 million from $90.9 million, driven by improved operating income and a retrospective change in accounting for maintenance costs.

Key figure
Net income $2.5M
4:33 PM ET 10-Q
Financial Results Euronet Worldwide, Inc. EEFT

Euronet Worldwide Q3 2026 Results: Net Income $114M, Down 6.9% YoY

For the nine months ended September 30, 2026, Euronet Worldwide reported revenues of $3,281.3 million, a 4.6% increase over the prior year, though net income attributable to the company decreased to $228.5 million from $258.0 million. The company's balance sheet remains liquid with $955.4 million in cash, despite significant share repurchases totaling $202.0 million during the first nine months of 2026.

Key figure
Net income $114M · -6.9% YoY
4:33 PM ET 8-K
Financial Results Primerica, Inc. PRI

Primerica Financial Results

Primerica reported third quarter 2026 results featuring record investment sales of $4.4 billion, up 19% year-over-year, and total revenues of $902 million. The company returned $159 million to stockholders through share repurchases and dividends while maintaining a life-licensed sales force of over 147,000 representatives.

Term
Q3 2026

“In the third quarter, Primerica’s financial performance underscored the consistency of our business fundamentals, driven by our unique operating model that is purpose-built to help middle-income families achieve financial security. Stable earnings in our Term Life segment and record investment sales continue to drive earnings momentum. These results reflect the dedication of our independent sales force and their commitment to helping families build a more secure future.”

Glenn Williams, Chief Executive Officer
4:33 PM ET 10-Q
Financial Results American Bitcoin Corp. ABTC

American Bitcoin Q3 2026 Results: Net Income $126M, Up 3525.5% YoY

American Bitcoin Corp. reported a significant turnaround in the third quarter of 2026 with net income of $126.0 million, driven by a $197.3 million gain on digital assets. Despite this quarterly success, the company maintained a net loss of $13.0 million for the nine months ended September 30, 2026, while continuing to scale its Bitcoin accumulation and mining operations.

Key figure
Net income $126M · +3525.5% YoY
4:33 PM ET 10-Q
Financial Results Acadia Healthcare Company, Inc. ACHC

Acadia Healthcare Company Q3 2026 Results: Net Income $34.5M, Down 4.9% YoY

For the quarter ended September 30, 2026, Acadia Healthcare reported revenue of $895.3 million, a 5.1% increase over the prior year. Net income attributable to the company was $34.5 million, down slightly from $36.2 million in 2025, while the company significantly improved its operating cash flow to $321.5 million for the first nine months of the year.

Key figure
Net income $34.5M · -4.9% YoY
4:33 PM ET 8-K
Financial Results Magnachip Semiconductor Corp MX

Magnachip Semiconductor Financial Results

Magnachip Semiconductor reported Q3 2026 revenue of $44.0 million, which was within its guidance range, though gross margins of 14.0% fell below expectations due to unfavorable foreign exchange movements. The company highlighted a $5 million strategic equity investment from Navitas Semiconductor and the launch of 15 new sixth-generation E6 Super-Junction MOSFETs. CEO Chae Lee noted that while near-term headwinds remain, the company is accelerating new-generation product development to move beyond price-based competition.

Term
Q3 2026

“While headwinds to our near-term financial performance remain, I am encouraged by the progress we are making in transforming Magnachip. We have significantly accelerated new-generation product development, established a clear roadmap for differentiated solutions, and strengthened our strategic partnership with Navitas Semiconductor. Our objective is to move beyond competing primarily on price to delivering innovative power semiconductor solutions that address increasingly complex customer requirements. Although this transformation will take time, I believe we are building the foundation for stronger competitive positioning, sustainable growth and improved profitability.”

Chae Lee, Chief Executive Officer of Magnachip
4:33 PM ET 8-K
Financial Results Cognex Corp CGNX

Cognex Financial Results

Cognex reported record third-quarter revenue of $313 million, a 13% increase year-over-year, driven by broad strength across major end markets. The company achieved significant margin expansion with an Adjusted EBITDA margin of 35.5% and announced a definitive agreement to acquire RealSense, Inc. to bolster its AI-powered machine vision and robotic perception capabilities.

Term
Q3 2026

“Our third-quarter results reflect strong execution across the business, with record revenue, broad-based growth across most of our major end markets, and continued progress against our strategic objectives. We believe we are strengthening our leadership in AI-powered machine vision through innovation, expanding our long-term growth opportunity through the announced acquisition of RealSense, and continuing to help position Cognex to benefit from what we see as powerful trends in automation, robotics, and artificial intelligence.”

Matt Moschner, President and CEO

“We believe Q3 was another strong proof point for our profitable growth strategy. Record revenue, significant margin expansion, and Adjusted EBITDA flow-through above 100% demonstrate the progress we have made transforming our operating model. Our strong balance sheet and disciplined capital allocation strategy enabled us to pursue the RealSense acquisition, while retaining flexibility to invest in both organic and inorganic growth opportunities with the potential to create further value for shareholders.”

Dennis Fehr, Senior Vice President of Finance and Chief Financial Officer
4:33 PM ET 8-K
Financial Results Phibro Animal Health Corp PAHC

Phibro Animal Health Financial Results

Phibro Animal Health reported Q1 2027 net sales of $386.8 million, a 6% increase year-over-year, driven by growth in Mineral Nutrition and Performance Products. The company maintained its full-year fiscal 2027 guidance despite regulatory headwinds for virginiamycin in Brazil. Additionally, shareholders ratified the election of three Class I directors and the appointment of PwC as auditors at the annual meeting.

Term
Q1 2027

“First quarter results exceeded our expectations and grew on top of a strong first quarter last year. The outperformance was led largely by a strong start to the year in Mineral Nutrition and Performance Products while our core Animal Health business delivered sales in line with our plan and Adjusted EBITDA ahead of plan, including the benefit of certain costs that shifted into the second quarter.”

Dani Bendheim, President and Chief Executive Officer

“Improving working capital and cash conversion is a top priority, and we are committed to delivering meaningful progress during fiscal 2027.”

Dani Bendheim, President and Chief Executive Officer
4:33 PM ET 10-Q
Financial Results Mayville Engineering Company, Inc. MEC

Mayville Engineering Company Q3 2026 Results: Turns Profitable, Net Income $424K

Mayville Engineering Company reported net sales of $170.4 million for the third quarter of 2026, an increase from $144.3 million in the prior year period. Despite the revenue growth, the company recorded a net loss of $9.8 million for the first nine months of 2026, primarily driven by higher cost of sales, increased interest expenses, and a $1.5 million impairment charge.

Key figure
Net income $424K
4:33 PM ET 10-Q
Financial Results Eagle Materials Inc EXP

Eagle Materials Q2 2026 Results: Net Income $112M, Down 18.8% YoY

Eagle Materials Inc. reported a decrease in net earnings for the quarter ended September 30, 2026, to $111.5 million compared to $137.4 million in the prior year, despite a slight revenue increase to $652.7 million. The decline was primarily driven by higher cost of goods sold and increased corporate general and administrative expenses.

Key figure
Net income $112M · -18.8% YoY
4:33 PM ET 10-Q
Financial Results Dave Inc. DAVE

Dave Q3 2026 Results: Net Income $63.8M, Down 30.7% YoY

Dave Inc. reported a significant increase in cash and cash equivalents to $269.9 million as of September 30, 2026, largely driven by the issuance of $193.5 million in convertible notes. The company also noted a decrease in net member receivables and highlighted ongoing legal risks, including a Department of Justice lawsuit.

Key figure
Net income $63.8M · -30.7% YoY
4:32 PM ET 8-K
Loan & Debt Middleby Corp MIDD

Middleby $1B Debt Financing with Bank of America, N.A.

The Middleby Corporation entered into a $3.0 billion Ninth Amended and Restated Credit Agreement, consisting of a $2.0 billion multicurrency revolving facility and a $1.0 billion USD term loan A facility. The new facilities refinance existing debt and provide capital for working capital, acquisitions, and share repurchases through a maturity date of November 4, 2031.

Value
$1B
Counterparty
Bank of America, N.A.
Term
5 years
4:32 PM ET 8-K
Financial Results Mks Inc MKSI

Mks Financial Results

MKS Inc. reported record third-quarter 2026 financial results with revenue of $1.41 billion and GAAP net income of $236 million, exceeding the high end of its guidance. Alongside the results, the company announced a new $500 million share repurchase program and a quarterly cash dividend.

“Our business momentum continued to build in the third quarter. Revenue in each of our end markets was at or above the high end of our guidance, led by 54% year-over-year growth in Semiconductor and 43% growth in Electronics & Packaging. From chips to substrates and advanced PCBs, the fundamental challenges of stacking, scaling, and new materials are becoming more integral in the AI era. MKS brings the broadest set of capabilities across both the semiconductor and advanced packaging markets to deliver foundational innovation, and that is driving robust orders and new design wins that set us up for continued strong performance.”

John T.C. Lee, President and Chief Executive Officer

“Q3 performance exceeded the high end of our guidance ranges for revenue and EPS, and we’re poised for a strong finish to 2026. Our business model is delivering scale benefits that, combined with accelerating revenue, are driving gross and operating margin expansion, strong earnings growth and cash generation. With our exposure to attractive growth markets, mix of equipment solutions and consumables, and a healthy balance sheet, MKS is well positioned to generate significant, durable shareholder returns.”

Ram Mayampurath, Executive Vice President and Chief Financial Officer
4:32 PM ET 8-K
Financial Results Xperi Inc. XPER

Xperi Financial Results

Xperi Inc. reported Q3 2026 financial results with revenue of $114.0 million, driven by a doubling of Media Platform revenue and significant growth in advertising. The company also announced the planned retirement of CFO Robert Andersen in 2027 and raised its full-year outlook for adjusted EBITDA margin and operating cash flow.

Term
Q3 2026

“As expected, our success in building our TiVo One footprint has begun to drive substantial growth in advertising and related revenue. The selection of TiVo’s Operating System by MediaMarktSaturn, the largest electronics retailer across Europe with more than 1,000 stores, demonstrates the benefit of our independent media platform solution, the strength of our retail media product offerings, and our unique competitive position in the market.”

Jon Kirchner, chief executive officer of Xperi

“Additionally, today we are announcing that our CFO, Robert Andersen, will retire from Xperi as part of a planned transition. Robert will continue in his current role until his successor is on board. On behalf of the Board of Directors and all team members at Xperi, I would like to thank Robert for his many years of dedicated leadership at the Company.”

Jon Kirchner, chief executive officer of Xperi
4:32 PM ET 10-Q
Financial Results Martin Marietta Materials Inc MLM

Martin Marietta Materials Q3 2026 Results: Net Income $256M, Down 38.2% YoY

Martin Marietta Materials Inc. filed its Form 10-Q on November 4, 2026, detailing the company's quarterly financial performance and operational results within the building materials sector. The report includes consolidated statements of earnings, comprehensive income, and cash flows for the period ending September 30, 2026.

Key figure
Net income $256M · -38.2% YoY
4:32 PM ET 8-K
Executive Compensation HP Inc HPQ

HP Executive Compensation

HP Inc. has appointed former GSK CEO Emma Walmsley as its new Chief Executive Officer, effective January 4, 2027, succeeding Interim CEO Bruce Broussard. Walmsley's compensation package includes a $1.45 million base salary, a 200% target bonus, and a $30 million one-time inducement equity award. Bruce Broussard will transition to the role of Chair of the Board upon Walmsley's start date.

4:32 PM ET 10-Q
Financial Results Cytokinetics Inc CYTK

Cytokinetics Q3 2026 Results: Net Loss of $190M, Loss Narrows

Cytokinetics filed its 10-Q for the period ending September 30, 2026, reporting 139,303,351 shares of common stock outstanding as of November 2, 2026. The company continues to advance its clinical pipeline, including aficamten and omecamtiv mecarbil, supported by various financing and royalty agreements with Royalty Pharma and Bayer.

Key figure
Net loss $190M
4:32 PM ET 8-K
Capital Raise OpenWorld, Inc. OPNW

OpenWorld Capital Raise

Stockholders holding 50.27% of OpenWorld's voting power approved the issuance of up to 5,035,970 shares of common stock upon the exercise of Series A and Series B warrants. The approval, conducted via written consent, satisfies Nasdaq Listing Rule 5635(d) requirements related to a registered direct offering previously announced on October 30, 2026.

4:32 PM ET Form 4
Insider Selling Ibotta, Inc. IBTA

Ibotta CTO Luke Roy Swanson Sells $3.06M of Stock

Luke Roy Swanson, CTO, sold 53,462 shares of Ibotta, Inc. at $48.87 to $65.81 a share (average $57.30) in 11 transactions, worth $3.06M in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 186,146 (-0.3%).

Value
$3.06M
Shares
53,462
Average price
$57.30
Role
CTO
Holding change
-0.3%
Trade date
Nov 2, 2026 to Nov 3, 2026
4:32 PM ET Form 4
Insider Selling Lcnb Corp LCNB

Lcnb EVP Michael Robert Miller Sells $36.4K of Stock

Michael Robert Miller, EVP, sold 1,817 shares of Lcnb Corp at $20.02 a share, worth $36.4K in total on Nov 4, 2026. Shares held after the trade: 17,957 (-9.2%).

Value
$36.4K
Shares
1,817
Price
$20.02
Role
EVP
Holding change
-9.2%
Trade date
Nov 4, 2026
4:32 PM ET 8-K
Capital Raise Cohen & Steers Income Opportunities REIT, Inc. CNSREIT

Cohen & Steers Income Opportunities REIT Capital Raise of $8.27M

Cohen & Steers Income Opportunities REIT, Inc. issued multiple classes of common shares in an unregistered private placement on November 2, 2026. The company sold a total of 668,042 shares across Class P, B, R-I, R-S, and M-I for aggregate consideration of approximately $8.27 million. The offering was conducted under Section 4(a)(2) and Regulation D exemptions.

Value
$8.27M
4:32 PM ET 8-K
Capital Raise Blackstone Real Estate Income Trust, Inc. BSTT

Blackstone Real Estate Income Trust Capital Raise of $23.4M

Blackstone Real Estate Income Trust, Inc. sold approximately $23.4 million of unregistered Class S-2 common stock in a continuous private offering to accredited investors. The shares were priced at the company's net asset value per share as of September 30, 2026, plus applicable upfront selling commissions.

Value
$23.4M
4:32 PM ET 8-K
Clinical Trial Data Citius Pharmaceuticals, Inc. CTXR

Citius Pharmaceuticals Clinical Trial Data

Citius Pharmaceuticals' subsidiary, Citius Oncology, presented health-related quality of life (HRQoL) data from its pivotal Study 302 of LYMPHIR in patients with relapsed or refractory cutaneous T-cell lymphoma. The data showed that patients who responded to the treatment reported sustained improvements in skin-related quality of life measures and significant reductions in pruritus (itching).

Counterparty
European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG)
4:32 PM ET 8-K
Clinical Trial Data Citius Oncology, Inc. CTOR

Citius Oncology Clinical Trial Data

Citius Oncology announced positive health-related quality of life (HRQoL) results from its pivotal Study 302 of LYMPHIR in patients with relapsed or refractory cutaneous T-cell lymphoma. Data presented at the EORTC-CLTG 2026 Annual Meeting showed that patients who responded to treatment reported sustained improvements in skin-related quality of life and significant reductions in pruritus (itching).

4:32 PM ET 10-Q
Financial Results Innoviva, Inc. INVA

Innoviva Q3 2026 Results: Net Loss of $73.9M

Innoviva, Inc. reported total revenue of $323.7 million for the nine months ended September 30, 2026, an increase from $296.7 million in the prior year period, driven by higher net product sales. Despite the revenue growth, the company experienced a significant net loss of $73.9 million in the third quarter of 2026, primarily due to $139.5 million in negative fair value adjustments on equity and long-term investments.

Key figure
Net loss $73.9M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.